PORTLAND, Maine, (May 31, 2022) – A groundbreaking study investigating the results of ElleVet Sciences CBD + CBDA oil and its efficacy on dogs experiencing itchy skin has been completed was completed and results show a resounding success. While CBD has been widely considered a potential supportive option for skin itchiness in dogs, few studies have examined its efficacy in canine populations prior to this research.
Analysis of the data shows that over 65% of the dogs enrolled in the study showed a noticeable improvement in skin itchiness. The paper is published in Veterinary Dermatology, a prestigious veterinary publication.
The paper can be found at https://onlinelibrary.wiley.com/doi/10.1111/vde.13077
(Copy and paste link into your web browser).
The research team, led by Dr. Andrew Rosenberg of the Dermatology Center of New York and New Jersey, conducted a year-long study examining a month-long treatment in placebo-controlled clinical trial in which dogs were given either a placebo or ElleVet CBD + CBDA oil. When compared to the placebo group, itchiness scores reported by owners dropped significantly for dogs receiving the ElleVet oil. All dogs enrolled had not responded to the sesame oil base as a control, indicating a meaningful positive impact of ElleVet on itchiness — one of the most common concerns among dog owners. No significant unwanted reactions were noted by owners, and when asked whether they would continue with ElleVet, all owners who observed positive responses were keen to do so.
Chief Medical Officer of ElleVet, Dr. Joseph Wakshlag, DVM, PhD, DACVIM (Nutrition), DACVSMR says, “ This is a really positive response since these dogs were all refractory to commonly used products. This can be a regimen that is safe and effective and is a worthwhile addition to the current regimen and could be considered a first line of defense and can be used in conjunction with other products when necessary. This study was a huge success and we at ElleVet are extremely excited to share the results with the veterinary community."
Dr. Wakshlag added, “The administration amounts in the study was specific for dogs experiencing itchy skin, highlighting the need for accurate administration guidance in CBD + CBDA products. 65% of dogs had a clinically meaningful reduction in itching, which makes this study a resounding success."
About ElleVet Sciences
ElleVet Sciences is a leading science-driven animal health company headquartered in South Portland, Maine. As the first organization to conduct successful clinical trials on the safety and efficacy of CBD + CBDA for pets, ElleVet continues to lead the field through research and innovation in collaboration with top veterinary professionals and institutions. The company has pioneered and patented safe, effective products for dogs, cats, and horses, offering support for mobility, stress, canine skin health, and canine brain function. Carried by thousands of veterinary clinics across the US, ElleVet is committed to improving the lives of companion animals, with both heart and science at the core of its mission.